Mylan, Teva And Generic Delzicol Wound Allergan
Earlier this week U.S. District Judge Rodney Gilstrap dismissed Allergan's (AGN) suit against Mylan (MYL) and Teva (TEVA) for patent infringement of Delzicol, the...
Teva: Will The Dividend Survive?
Teva's (TEVA) $40 billion acquisition of Allergan's (AGN) generics business has left the company debt-laden, while its generics operations are experiencing pricing pressure. After...
Trump And The Global Economy, 10/24 6PM – 8PM, Livestreamed Here
Trump And The Global Economy Town Hall brings together a cross-section of individuals to discuss everything from President Trump's policies on economics, immigration, and...
President Trump – Drug Companies ‘Getting Away With Murder’
Monday President Trump again voiced the need to tamp down the rising accelerating drug prices:
https://twitter.com/NBCNews/status/919960064370270208
Another thing we are doing as it relates to people's...
Allergan Punished After Judge Invalidates Restasis Patents
Allergan's (AGN) fight with generic rivals pursuant to its Restasis patents took another twist Monday. Judge William Bryson ruled Restasis patents were invalid due...
The Final Straw For Mallinckrodt?
When it rains it pours for Mallinckrodt (MNK). Last month a Delaware judge invalidated 11 patents pursuant to Inomax, one of the company's top-selling...
Mylan Calls Allergan’s Mohawk Deal A ‘Sham’
Allergan (AGN) is suing generic drug makers Mylan (MYL) and Teva (TEVA) for patent infringement pursuant to Restasis, its blockbuster dry eye treatment. An...
Teva Maneuvers To Match 30% Discounts For Generic Copaxone
The major question surrounding Teva (TEVA) is how much Mylan's (MYL) generic Copaxone will impact Copaxone sales. The answer to that question began to...
SHAM! Allergan Says Mohawks Bought $14 Billion Patents With Immunity Promise
Allergan's odd patent transfer to the St. Regis Mohawk Tribe is gaining a lot of scrutiny. It sued rivals from offering generic Restasis, its...
Allergan Bulls Should Brace Themselves For Generic Restasis
Allergan's federal trial to block Teva (TEVA), Mylan (MYL) and Pfizer (PFE) from infringing upon its Restasis patents is heating up. After transferring the...
